Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

NCT00296374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Rosuvastatin
DRUG: Rosuvastatin
DRUG: Atorvastatin

Sponsor

AstraZeneca